This text is a review of the second edition of the book Hypertension: Physiopathology and Treatment, highlighting updates in basic research and clinical aspects of hypertension.
This outstanding book appears in a second edition six years after the appearance ofHypertension: Physiopathology and Treatmentin 1977, edited by Jacques Genest and associates. In their preface, the authors point out the necessity for updating the first edition of the book, particularly because of advances in the measurement of human plasma renin and catecholamines, improved understanding of the roles of dopamine, of renal prostaglandins and the kallikrein system, and increased awareness of the importance of defective permeability to sodium in the cellular membrane in hypertension. In the area of drug therapy they pay particular attention to the development of oral converting enzyme inhibitors. The imposing list of 135 authors is international in scope and includes a large number of names that are familiar to all who have an interest in hypertension because of their leadership both in basic research and in the clinical aspects of the subject. Happily,
Donald J. Breslin (Fri,) conducted a review in Hypertension. This text is a review of the second edition of the book Hypertension: Physiopathology and Treatment, highlighting updates in basic research and clinical aspects of hypertension.